Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.7526
-0.0814 ( -9.76% ) 497.6K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.7526
Previous close
$0.8340
Volume
497.6K
Market cap
$128.82M
Day range
$0.7520 - $0.8720
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Jan 07, 2025 |
| 8-k | 8K-related | 13 | Jan 06, 2025 |
| 8-k | 8K-related | 13 | Nov 21, 2024 |
| 10-q | Quarterly Reports | 64 | Nov 14, 2024 |
| 8-k | 8K-related | 14 | Nov 08, 2024 |
| 4 | Insider transactions | 1 | Nov 07, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 3 | Insider transactions | 1 | Nov 05, 2024 |